Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Desferrioxamine Mesilate for Injection

Approval Number

国药准字HJ20170147

CompanyNovartis Pharma Schweiz AG

Registration Date

December 20, 2021

Previous Approval Numbers

H20170147

Drug Information

Generic Name

注射用甲磺酸去铁胺

Trade Name

得斯芬

Dosage Form

注射剂

Strength

0.5g

Drug Type

化学药品

Registration Date

December 20, 2021

Expiry Date

December 19, 2026

Company Information

Applicant Company

Company NameNovartis Pharma Schweiz AG

Company Address

6343 Risch, Switzerland

Manufacturing Company

Company NameWasserburger Arzneimittelwerk GmbH

Company Address

Herderstrasse 2, 83512 Wasserburg, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy